Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Insulin levels linked to Alzheimer's disease

Insulin and its related proteins are produced in the brain, and according to researchers from Rhode Island Hospital and Brown Medical School, reduced levels of this combination can be linked to Alzheimer's disease. The findings are reported in the March issue of the Journal of Alzheimer's Disease.

7 Mar 2005

FDA has accepts new drug application for Exubera (inhaled human insulin powder)

Dr. John Patton, co-founder and chief scientific officer for Nektar reported that Pfizer and The Sanofi-Aventis Group have announced that the FDA has accepted for filing a new drug application for Exubera (inhaled human insulin powder).

3 Mar 2005

CPAP therapy helps control glucose levels among patients with Type II diabetes and sleep apnea

Patients with Type II diabetes who also suffer from obstructive sleep apnea can lower their glucose levels by receiving the most common sleep apnea therapy, a new study has found.

1 Mar 2005

First study to show cost-effectiveness of pre-diabetes intervention

More than 40 million Americans face a high risk of developing Type 2 diabetes, and it would cost a lot to give all of them intensive help with diet and exercise, or medication, to keep them from developing diabetes.

28 Feb 2005

Childhood obesity is a serious health problem in Australia

Professor Michael Booth, co-director of the University of Sydney's Centre for Overweight and Obesity, said teenagers were already showing signs of serious illness caused by their weight.

24 Feb 2005

Discovery could lead to the prevention, and possibly treatment of autoimmune diseases such as Type 1 diabetes

Scientists at the University of Maryland School of Medicine in Baltimore have identified a way to prevent Type I diabetes in rats that are genetically prone to develop the disease.

23 Feb 2005

Prozac, Xenical and Meridia may help type 2 diabetes patients lose weight

Three commonly used drugs - Prozac, Xenical and Meridia - may help type 2 diabetes patients lose small amounts of weight, although long-term benefits are not clear, a new review of 22 studies suggests.

20 Feb 2005

Olmesartan improves blood supply to kidneys

How do medications that block the renin-angiotensin system (RAS blockers) work to protect against kidney disease in people with diabetes? At least partly by improving the blood supply to the kidneys, suggests a study in the April Journal of the American Society of Nephrology.

17 Feb 2005

Link between diabetes and obesity

Scientists at Washington University School of Medicine in St. Louis used genetically modified mice to uncover a potentially important link between diabetes and obesity.

15 Feb 2005

Scientists show knocking out key signals will cause diabetes

Using a revolutionary technique to turn off chemical signals inside the cell, scientists at Joslin Diabetes Center have discovered that the different metabolic abnormalities present in type 2 diabetes can be caused by knocking out two key signals in liver cells.

11 Feb 2005

Short girls with underlying disease are not being diagnosed

Twice as many boys as girls are referred to medical specialists for evaluation of short stature or poor growth, according to a new study.

7 Feb 2005

Cardiac rehabilitation and secondary prevention protocols to imperative prevent recurrent heart attacks

Physicians should aggressively encourage patients to exercise and follow cardiac rehabilitation and secondary prevention protocols to prevent recurrent heart attacks, the American Heart Association recommends in its updated scientific statement on cardiac rehabilitation and secondary prevention of coronary heart disease.

27 Jan 2005

Major health problems in babies of diabetic mothers on the rise

During the past decade, babies born to women with type 2 diabetes have shown an increasing number of serious health problems -- including stillbirth and birth defects, such as brain, spine and heart congenital malformations that can lead to infant deaths, according to a study published in the February issue of Diabetes Care.

27 Jan 2005

Lack of the enzyme acetyl CoA carboxylase 2 turns fat cells into fat burners

Lack of the enzyme, acetyl CoA carboxylase 2 or ACC2, appears to turn the adipose or fat cells of mice into fat burners, explaining in part why the animals can eat more and weigh less than their normal counterparts, said Baylor College of Medicine researchers.

25 Jan 2005

Bariatric surgery for severely obese patients leads to weight loss and improves insulin sensitivity

In a study published in the current issue of The American Journal of Medicine, researchers from the State University of Campinas, São Paulo, Brazil; Catholic University, Rome, Italy; and the University of Pisa, Italy, found that the degree of improvement depended on the surgical technique used, comparing biliopancreatic diversion to gastric bypass.

25 Jan 2005

More studies on risks and benefits of COX-2 inhibitors

A group of studies published in the January 24 issue of Archives of Internal Medicine add to the growing body of medical literature about the cardiovascular risks that may be associated with the class of pain-relieving drugs known as COX-2 inhibitors.

24 Jan 2005

Orally ingested drug to help Type 2 diabetes sufferers

A new drug invented by Monash University researchers Paul Zimmet and Frank Ng could help Type 2 diabetes sufferers lower blood glucose levels and enhance the potency of insulin, with few side effects.

24 Jan 2005

Insight into potential mechanisms underlying type II diabetes

New research published in the premier issue of Cell Metabolism finds that a single brain region is sufficient for normal control of blood sugar and activity level by the fat hormone leptin. The same region also exerts significant, though more modest, control over leptin's effects on body weight.

19 Jan 2005

Role of ethnicity in nonalcoholic fatty liver disease

The first study to examine nonalcoholic fatty liver disease (NAFLD) among different ethnic and racial groups in the United States finds that Hispanics may be at a higher risk of developing the condition. The study is published in Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD). Published by John Wiley & Sons, Inc., Hepatology is available online via Wiley InterScience.

19 Jan 2005

Cellular fuel gauge could hold clue to diabetes

A molecule in the body could hold the key to explaining why people who exercise regularly are less likely to have illnesses such as type 2 diabetes.

19 Jan 2005

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Insulin levels linked to Alzheimer's disease

FDA has accepts new drug application for Exubera (inhaled human insulin powder)

CPAP therapy helps control glucose levels among patients with Type II diabetes and sleep apnea

First study to show cost-effectiveness of pre-diabetes intervention

Childhood obesity is a serious health problem in Australia

Discovery could lead to the prevention, and possibly treatment of autoimmune diseases such as Type 1 diabetes

Prozac, Xenical and Meridia may help type 2 diabetes patients lose weight

Olmesartan improves blood supply to kidneys

Link between diabetes and obesity

Scientists show knocking out key signals will cause diabetes

Short girls with underlying disease are not being diagnosed

Cardiac rehabilitation and secondary prevention protocols to imperative prevent recurrent heart attacks

Major health problems in babies of diabetic mothers on the rise

Lack of the enzyme acetyl CoA carboxylase 2 turns fat cells into fat burners

Bariatric surgery for severely obese patients leads to weight loss and improves insulin sensitivity

More studies on risks and benefits of COX-2 inhibitors

Orally ingested drug to help Type 2 diabetes sufferers

Insight into potential mechanisms underlying type II diabetes

Role of ethnicity in nonalcoholic fatty liver disease

Cellular fuel gauge could hold clue to diabetes

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in